Hairy cell leukemia with systemic lymphadenopathy: Detection of BRAF mutations in both lymph node and peripheral blood specimens

Internal Medicine

Volumn 54, Issue 11, 2015, Pages 1397-1402

  Okada, Kazuya ^a   Kunitomi, Akane ^a   Sakai, Kazuya ^a   Muranushi, Hiroyuki ^a   Okamoto, Yusuke ^a   Tsukamoto, Taku ^a   Sugiura, Hiroyuki ^a   Matsui, Hiroyuki ^a   Jo, Tomoyasu ^a   Ueda, Tomoaki ^a   Onishi, Tatsuhito ^a   Ide, Masaru ^b   Kimura, Shinya ^b   Notohara, Kenji ^a   Ueda, Yasunori ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Braf mutation; Hairy cell leukemia; Systemic lymphadenopathy

Indexed keywords

B RAF KINASE; FLUORODEOXYGLUCOSE F 18; INTERLEUKIN 2; LACTATE DEHYDROGENASE; BRAF PROTEIN, HUMAN;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HAIRY CELL LEUKEMIA; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; LEUKOPENIA; LYMPHADENOPATHY; LYMPHOID CELL; MIDDLE AGED; MUTATIONAL ANALYSIS; NEUTROPHIL COUNT; PANCYTOPENIA; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; REMISSION; SEQUENCE ANALYSIS; SPLENOMEGALY; THROMBOCYTOPENIA; GENETICS; LEUKEMIA, HAIRY CELL; LYMPH NODE; LYMPHATIC SYSTEM DISEASE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; LYMPH NODES; LYMPHATIC DISEASES; PANCYTOPENIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS B-RAF; SPLENOMEGALY;

EID: 84939556064     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.2944     Document Type: Article

References (31)

1. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood 13: 609-630, 1958.
2. Foucar K, Falini B, Catovsky D, Stein H. Hairy cell leukaemia. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, et al, Eds. International Agency for Research on Cancer (IARC), Lyon, 2008: 188-190.
3. Jonson JB, Grever MR. Hairy Cell Leukemia. In: Wintrobe’s Clinical Hematology. 13th ed. Greer JP, Arber DA, Glader B, et al, Eds. Lippincott Williams and Wilkins, Philadelphia, PA, 2014: 1929-1950.
4. Tiacci E, Liso A, Piris M, Falini B. Evolving concepts in the pathogenesis of hairy-cell leukaemia. Nat Rev Cancer 6: 437-448, 2006.
5. Piris M, Foucar K, Mollejo M, Campo E, Falini B. Splenic B-cell lymphoma/leukaemia, unclassificable. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Swerdlow SH, Campo E, Harris NL, et al, Eds. International Agency for Research on Cancer (IARC), Lyon, 2008: 191-193.
6. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
7. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med 364: 2305-2315, 2011.
8. Tiacci E, Schiavoni G, Forconi F, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 119: 192-195, 2012.
9. Arcaini L, Zibellini S, Boveri E, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 119: 188-191, 2012.
10. Blombery PA, Wong SQ, Hewitt CA, et al. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders. Haematologica 97: 780-783, 2012.
11. Suzuki S, Komori M, Hirai M, Ureshino N, Kimura S. Development of a novel, fully-automated genotyping system: principle and applications. Sensors 12: 16614-16627, 2012.
12. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317, 2003.
13. Grever MR. How I treat hairy cell leukemia. Blood 115: 21-28, 2010.
14. Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D; British Committee for Standards in Haematology. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant. Br J Haematol 156: 186-195, 2012.
15. Goodman GR, Burian C, Koziol JA, Saven A. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 21: 891-896, 2003.
16. Else M, Osuji N, Forconi F, et al. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/ refractory hairy cell leukemia. Cancer 110: 2240-2247, 2007.
17. Naik RR, Saven A. My treatment approach to hairy cell leukemia. Mayo Clin Proc 87: 67-76, 2012.
18. Else M, Dearden CE, Matutes E, et al. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 145: 733-740, 2009.
19. Mercieca J, Puga M, Matutes E, Moskovic E, Salim S, Catovsky D. Incidence and significance of abdominal lymphadenopathy in hairy cell leukaemia. Leuk Lymphoma 14: 79-83, 1994.
20. Mercieca J, Matutes E, Emmett E, Coles H, Catovsky D. 2 Chlorodeoxyadenosinein the treatment of hairy cell leukaemia: differences in response in patients with and without abdominal lymphadenopathy. Br J Haematol 93: 409-411, 1996.
21. Osman H, Roth T, Zhou J. Hairy cell lymphoma: a unique presentation of hairy cell leukaemia. Br J Haematol 162: 294, 2013.
22. Wellbrock C, Hurlstone A. BRAF as therapeutic target in melanoma. Biochem Pharmacol 80: 561-567, 2010.
23. Li Y, Nakamura M, Kakudo K. Targeting of the BRAF gene in papillary thyroid carcinoma. Oncol Rep 22: 671-681, 2009.
24. Andrulis M, Lehners N, Capper D, et al. Targeting the BRAF V600E mutation in multiple myeloma. Cancer Discov 3: 862-869, 2013.
25. Katsuki K, Shinohara K, Kameda N, Yamada T, Takeda K, Kamei T. Two cases of myelodysplastic syndrome with extramedullary polyclonal plasma cell proliferation and autoantibody production: possible role of soluble Fas antigen for production of excessive self-reactive B cells. Intern Med 37: 973-977, 1998.
26. Viny AD, Lichtin A, Pohlman B, Loughran T, Maciejewski J. Chronic B-cell dyscrasias are an important clinical feature of TLGL leukemia. Leuk Lymphoma 49: 932-938, 2008.
27. Tsai DE, Aqui NA, Tomaszewski JE, et al. Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder. Clin Transplant 19: 644-652, 2005.
28. Higuchi T, Tada J, Mori H, et al. Immunoblastic lymphadenopathy-like T cell lymphoma evolving into a massive plasma cell proliferation with biclonal paraproteinemia. Acta Haematol 100: 151-155, 1998.
29. Nordström M, Hardell L, Linde A, Schloss L, Näsman A. Elevated antibody levels to Epstein-Barr virus antigens in patients with hairy cell leukemia compared to controls in relation to exposure to pesticides, organic solvents, animals, and exhausts. Oncol Res 11: 539-544, 1999.
30. Sakamoto K, Aiba M, Katayama I, Sullivan JL, Humphreys RE, Purtilo DT. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia. Int J Cancer 24: 453-458, 1981.
31. Chapman PB, Hauschild A, Robert C, et al; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364: 2507-2516, 2011.